Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 151 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 5/21/2008 First Published: 1/5/2007


1.		Phase IV Randomized Study of Pregabalin in Preventing and Treating Chemotherapy-Induced Peripheral Neuropathy in Patients Undergoing Treatment With Oxaliplatin, Fluorouracil, and Leucovorin Calcium for Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				18 to 80				Pharmaceutical / Industry				PFIZER-A0081124 RAH-060919, NCT00380874


2.		Paclitaxel Plus Carboplatin With Endostar in Patients of Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 to 75				Pharmaceutical / Industry				XYL014 NCT00708812


3.		Pregabalin for Postoperative Pain in Women Undergoing Breast Cancer Surgery

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				65 and under				Other				IWK-4298-2008 NCT00785382


4.		Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Approved-not yet active				35 to 90				Other, Pharmaceutical / Industry				047838 NCT00805701


5.		Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture and Myelogram

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Approved-not yet active				4 to 14				Other				CAAE0450020300008 NCT00808171


6.		Second-Line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Pharmaceutical / Industry				simcere002 simcere0802, NCT00813332

Last Modified: 1/12/2009 First Published: 7/1/2002


7.		Phase II/III Randomized Study of Ginger for Chemotherapy-Related Nausea in Patients With Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care				Active				18 and over				NCI				URCC-U1902 URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742


8.		A Study of AVE8062 in Advanced-Stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				EFC10145 EudraCT 2007-003592-39, NCT00699517


9.		Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				40 to 75				Other				Hamamatsu 18-66 NCT00752115

First Published: 10/1/2008


10.		Phase II/III Randomized Study of Adjuvant Soy Protein Isolate in Preventing Recurrence in Patients Who Have Undergone Radical Prostatectomy for Stage II Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Biomarker/Laboratory analysis, Treatment				Active				40 to 75				NCI				UIC-2006-0706 2006-0706, NCT00765479

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute